NCT05953688Phase 2Terminated

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Study sponsor: Alumis Inc · ALMS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-08-13Actual
Enrollment · participants36Actual
Source updated2024-08-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview